Iain McGill

Back to Jobs

Iain McGill has served on our board of directors since August 2016. Mr. McGill has over 25 years of experience in the pharmaceutical and biotech sector and currently serves as Chief Executive Officer and member of the board of directors for Quell Therapeutics, a privately held, innovating cell and gene therapy company in the immune dysregulation field. Between June 2012 and June 2019 Mr. McGill served as Senior Vice President, Europe and Rest of World for Jazz Pharmaceuticals plc with responsibility for all ex-U.S. operations. Between 2010 and 2012, Mr. McGill served as Chief Commercial Officer of EUSA Pharma, a specialty pharmaceutical company based in the UK, which was acquired by Jazz Pharmaceuticals in 2012. From 2006 to 2009, Mr. McGill served as Vice President and Global Business Manager for Transplantation and Immunology at Wyeth, a pharmaceutical company acquired by Pfizer Inc. Previously, Mr. McGill held general management and commercial leadership positions with increasing responsibility over thirteen years at Novartis and Roche. He holds a Bachelor of Science degree in Biochemistry from the University of London.

Apply Now